Zurich Insurance Group LTD Incyte Corp Transaction History

Zurich Insurance Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $2.17 Million - $2.84 Million	-29,703 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $2.16 Million - $2.57 Million	29,703 New	29,703 $2.21 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $1.61 Million - $2.22 Million	-26,422 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $147,514 - $179,340	1,776 Added 7.21%	26,422 $2.2 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $282,738 - $352,365	3,022 Added 13.98%	24,646 $2.33 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.36 Million - $2.99 Million	21,624	21,624 $2.52 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

Stay updated on Zurich Insurance Group LTD with notifications on news.